Q3 2024 Holdings
Filed 2024-11-14 | 79 holdings | $339.7M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Vera Therapeutics Inc(VERA) | CL A | 92337R101 | $30.2M | 684,000 | 8.9% |
| Adma Biologics Inc(ADMA) | COM | 000899104 | $27.2M | 1,360,000 | 8.0% |
| Sarepta Therapeutics Inc(SRPT) | COM | 803607100 | $21.2M | 170,000 | 6.2% |
| Edwards Lifesciences Corp(EW) | COM | 28176E108 | $14.6M | 222,000 | 4.3% |
| Xenon Pharmaceuticals Inc(XENE) | COM | 98420N105 | $14.2M | 360,600 | 4.2% |
| Zevra Therapeutics Inc(ZVRA) | COM NEW | 488445206 | $11.8M | 1,700,000 | 3.5% |
| Intra-Cellular Therapies Inc(ITCIEUR) | COM | 46116X101 | $11.3M | 154,000 | 3.3% |
| Soleno Therapeutics Inc(SLNO) | COM | 834203309 | $10.7M | 212,909 | 3.2% |
| Glaukos Corp(GKOS) | COM | 377322102 | $10.0M | 77,000 | 3.0% |
| Insmed Inc(INSM) | COM PAR $.01 | 457669307 | $9.5M | 130,000 | 2.8% |
| Merit MED SYS Inc(MMSI) | COM | 589889104 | $8.4M | 85,000 | 2.5% |
| Rezolute Inc(RZLT) | COM NEW | 76200L309 | $8.2M | 1,700,000 | 2.4% |
| Vaxcyte Inc(PCVX) | COM | 92243G108 | $8.2M | 72,000 | 2.4% |
| Avadel Pharmaceuticals PLC | COM SHS | G29687103 | $8.0M | 610,000 | 2.4% |
| Viking Therapeutics Inc(VKTX) | COM | 92686J106 | $8.0M | 126,000 | 2.3% |
| Catalyst Pharmaceuticals Inc(CPRX) | COM | 14888U101 | $7.7M | 385,000 | 2.3% |
| Contineum Therapeutics Inc(CTNM) | CL A | 21217B100 | $7.1M | 369,126 | 2.1% |
| Arrowhead Pharmaceuticals in(ARWR) | COM | 04280A100 | $6.9M | 355,000 | 2.0% |
| Savara Inc(SVRA) | COM | 805111101 | $6.7M | 1,575,000 | 2.0% |
| Irhythm Technologies Inc(IRTC) | COM | 450056106 | $6.4M | 86,000 | 1.9% |
| Evolus Inc(EOLS) | COM | 30052C107 | $5.8M | 355,000 | 1.7% |
| Establishment Labs Hldgs Inc(ESTA) | COM | G31249108 | $5.7M | 131,000 | 1.7% |
| Rxsight Inc(RXST) | COM | 78349D107 | $5.5M | 112,000 | 1.6% |
| Axsome Therapeutics Inc(AXSM) | COM | 05464T104 | $5.2M | 58,000 | 1.5% |
| Skye Bioscience Inc(SKYE) | COM NEW | 83086J200 | $5.1M | 1,315,146 | 1.5% |
| Xtant MED Hldgs Inc(XTNT) | COM NEW | 98420P308 | $5.0M | 7,415,413 | 1.5% |
| Larimar Therapeutics Inc(LRMR) | COM | 517125100 | $4.5M | 693,000 | 1.3% |
| Capricor Therapeutics Inc(CAPR) | COM NEW | 14070B309 | $4.3M | 285,000 | 1.3% |
| Pulmonx Corp(LUNG) | COM | 745848101 | $4.1M | 500,000 | 1.2% |
| Corbus Pharmaceuticals Hldgs(CRBP) | COM NEW | 21833P301 | $4.0M | 195,000 | 1.2% |
| Keros Therapeutics Inc(KROS) | COM | 492327101 | $4.0M | 69,000 | 1.2% |
| The Realreal Inc(REAL) | COM | 88339P101 | $4.0M | 1,270,000 | 1.2% |
| Perspective Therapeutics Inc(CATX) | COM NEW | 46489V302 | $3.9M | 290,000 | 1.1% |
| Biohaven LTD(BHVN) | COM | G1110E107 | $3.7M | 75,000 | 1.1% |
| Oric Pharmaceuticals Inc(ORIC) | COM | 68622P109 | $3.6M | 355,000 | 1.1% |
| Structure Therapeutics Inc(GPCR) | SPONSORED ADS | 86366E106 | $3.1M | 70,000 | 0.9% |
| Outlook Therapeutics Inc(OTLK) | COM | 69012T305 | $2.9M | 541,549 | 0.9% |
| Vericel Corp(VCEL) | COM | 92346J108 | $2.9M | 68,000 | 0.8% |
| Cybin Inc(HELP) | COM NEW | 23256X407 | $2.8M | 317,000 | 0.8% |
| Terns Pharmaceuticals Inc(TERN) | COM | 880881107 | $2.8M | 330,000 | 0.8% |
| Ocugen Inc(OCGN) | COM | 67577C105 | $2.3M | 2,350,000 | 0.7% |
| Moonlake Immunotherapeutics(MLTX) | CLASS A ORD | 61559X104 | $2.0M | 40,000 | 0.6% |
| Bicycle Therapeutics PLC(BCYC) | SPONSORED ADS | 088786108 | $1.9M | 85,000 | 0.6% |
| Annovis BIO Inc(ANVS)Put | COM | 03615A108 | $1.9M | 236,400 | 0.6% |
| Veru Inc(VERUEUR) | COM | 92536C103 | $1.6M | 2,028,534 | 0.5% |
| Atricure Inc(ATRC) | COM | 04963C209 | $1.5M | 54,000 | 0.4% |
| Larimar Therapeutics Inc(LRMR)Call | COM | 517125100 | $1.3M | 196,000 | 0.4% |
| Cytomx Therapeutics Inc(CTMX) | COM | 23284F105 | $1.1M | 915,000 | 0.3% |
| Envveno Medical Corporation | COM | 29415J106 | $802.8K | 238,920 | 0.2% |
| Tempest Therapeutics Inc(OVASUSD) | COM | 87978U108 | $763.0K | 545,000 | 0.2% |